PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Mar 2020 12:02 PM
RNS
Price Monitoring Extension
05 Mar 2020 04:40 PM
RNS
Second Price Monitoring Extn
05 Mar 2020 04:35 PM
RNS
Price Monitoring Extension
03 Mar 2020 04:40 PM
RNS
Second Price Monitoring Extn
03 Mar 2020 04:36 PM
RNS
Price Monitoring Extension
03 Mar 2020 12:02 PM
RNS
Price Monitoring Extension
03 Mar 2020 07:00 AM
RNS
Clinical Trial Initiated Of Wholly-Owned Candidate
02 Mar 2020 07:00 AM
RNS
Total Voting Rights
27 Feb 2020 04:41 PM
RNS
Second Price Monitoring Extn
27 Feb 2020 04:36 PM
RNS
Price Monitoring Extension
25 Feb 2020 07:00 AM
RNS
Akili ADHD Study in The Lancet Digital Health
18 Feb 2020 07:00 AM
RNS
PRTC to Present at Leerink Healthcare Conference
03 Feb 2020 04:40 PM
RNS
Second Price Monitoring Extn
03 Feb 2020 04:35 PM
RNS
Price Monitoring Extension
03 Feb 2020 07:00 AM
RNS
Total Voting Rights
23 Jan 2020 07:00 AM
RNS
PureTech Receives $200M from KRTX Shares
15 Jan 2020 01:04 PM
RNS
Akili's New ADHD Trial Met Primary Endpoint
13 Jan 2020 12:07 PM
RNS
Second Price Monitoring Extn
13 Jan 2020 12:02 PM
RNS
Price Monitoring Extension
02 Jan 2020 07:00 AM
RNS
Total Voting Rights
19 Dec 2019 07:00 AM
RNS
Follica Positive Androgenetic Alopecia Study
17 Dec 2019 12:00 PM
RNS
Gelesis Partners with US Telehealth Provider
12 Dec 2019 01:04 PM
RNS
Akili Meets Primary Endpoint in MDD Clinical Trial
10 Dec 2019 12:02 PM
RNS
Price Monitoring Extension
10 Dec 2019 07:00 AM
RNS
Vedanta & BMS Begin Immuno-Oncology Clinical Study
09 Dec 2019 07:00 AM
RNS
Gelesis Attracts $84M in New Capital for Launch
05 Dec 2019 07:00 AM
RNS
Vedanta MultiDrug Resistance Program Granted $5.8M
02 Dec 2019 07:00 AM
RNS
Total Voting Rights
25 Nov 2019 12:02 PM
RNS
Price Monitoring Extension
21 Nov 2019 07:00 AM
RNS
Karuna Prices $250M Follow-On Offering
18 Nov 2019 11:03 AM
RNS
Karuna Successful Ph2 Schizophrenia Study Readout
15 Nov 2019 12:51 PM
RNS
resTORbio Update on Phase 3 Trial
13 Nov 2019 07:00 AM
RNS
PureTech to Present at Jefferies London Conference
05 Nov 2019 01:00 PM
RNS
PRTC Presents Novel Oncology Program Data at SITC
05 Nov 2019 11:00 AM
RNS
Gelesis Shares New Plenity Safety & Efficacy Data
28 Oct 2019 12:07 PM
RNS
Second Price Monitoring Extn
28 Oct 2019 12:02 PM
RNS
Price Monitoring Extension
24 Oct 2019 07:00 AM
RNS
Sonde Names Healthcare Tech Exec David Liu as CEO
18 Oct 2019 04:40 PM
RNS
Second Price Monitoring Extn
18 Oct 2019 04:35 PM
RNS
Price Monitoring Extension
04 Oct 2019 04:40 PM
RNS
Second Price Monitoring Extn
04 Oct 2019 04:35 PM
RNS
Price Monitoring Extension
04 Oct 2019 12:07 PM
RNS
Second Price Monitoring Extn
04 Oct 2019 12:02 PM
RNS
Price Monitoring Extension
02 Oct 2019 07:00 AM
RNS
Minority Stake Acquisition & PDMR Notification
01 Oct 2019 04:40 PM
RNS
Second Price Monitoring Extn
01 Oct 2019 04:35 PM
RNS
Price Monitoring Extension
01 Oct 2019 01:15 PM
RNS
Vor Appoints Senior Cell & Gene Therapy Leaders
01 Oct 2019 07:00 AM
RNS
Total Voting Rights
23 Sep 2019 04:40 PM
RNS
Second Price Monitoring Extn

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings